99 related articles for article (PubMed ID: 2009881)
1. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin.
Chomarat M; Espinouse D
Eur J Clin Microbiol Infect Dis; 1991 Jan; 10(1):44. PubMed ID: 2009881
[No Abstract] [Full Text] [Related]
2. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.
Viscoli C; Moroni C; Boni L; Bruzzi P; Comelli A; Dini G; Fabbri A; Secondo V; Terragna A
Rev Infect Dis; 1991; 13(3):397-404. PubMed ID: 1866542
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus species as emerging pathogens in neutropenic patients.
Fruchart C; Salah A; Gray C; Martin E; Stamatoullas A; Bonmarchand G; Lemeland JF; Tilly H
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):681-4. PubMed ID: 9352263
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
5. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Shahar A; Berner Y; Levi S
Ann Pharmacother; 2000 Feb; 34(2):263-4. PubMed ID: 10676837
[No Abstract] [Full Text] [Related]
6. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
Schaison G; Leverger G; Pappo M; Chiche D
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
[TBL] [Abstract][Full Text] [Related]
7. Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia.
Sriskandan S; Lacey S; Fischer L
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):649-50. PubMed ID: 8223672
[No Abstract] [Full Text] [Related]
8. Clostridium tertium septicemia in patients with neutropenia.
Speirs G; Warren RE; Rampling A
J Infect Dis; 1988 Dec; 158(6):1336-40. PubMed ID: 3198941
[TBL] [Abstract][Full Text] [Related]
9. Fatal toxic epidermal necrolysis associated with ceftazidine and vancomycin therapy: a report of two cases.
Thestrup-Pedersen K; Hainau B; Al'Eisa A; Al'Fadley A; Hamadah I
Acta Derm Venereol; 2000; 80(4):316-7. PubMed ID: 11028879
[No Abstract] [Full Text] [Related]
10. CAPD peritonitis caused by Lactobacillus rhamnosus.
Sanyal D; Bhandari S
J Hosp Infect; 1992 Dec; 22(4):325-7. PubMed ID: 1363113
[No Abstract] [Full Text] [Related]
11. [Ceftazidime for the treatment of infections in neutropenic children].
Leverger G; Arlet G; Bancillon A; Schaison G
Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
Wang FD; Liu CY; Hsu HC; Gau JP; Chau WK; Haung ML; Ho CH
Chemotherapy; 1999; 45(5):370-9. PubMed ID: 10473925
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus epidermidis septicemia in children with leukemia and lymphoma.
Friedman LE; Brown AE; Miller DR; Armstrong D
Am J Dis Child; 1984 Aug; 138(8):715-9. PubMed ID: 6741885
[TBL] [Abstract][Full Text] [Related]
14. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
Koeppler H; Pflueger KH; Seitz R; Havemann K
Infection; 1989; 17(3):142-5. PubMed ID: 2661438
[TBL] [Abstract][Full Text] [Related]
15. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
[TBL] [Abstract][Full Text] [Related]
18. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
[TBL] [Abstract][Full Text] [Related]
19. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
